We are live on ! Find out more
ACOR

Acorda Therapeutics
ACOR

Delisted

ACOR was delisted on the 11th of April, 2024.

Back to rankings

163 hedge funds and large institutions have $1.17B invested in Acorda Therapeutics in 2013 Q4 according to their latest regulatory filings, with 28 funds opening new positions, 64 increasing their positions, 47 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

65% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 17

36% more repeat investments, than reductions

Existing positions increased: 64 | Existing positions reduced: 47

24% more call options, than puts

Call options by funds: $1.22M | Put options by funds: $984K

7% more funds holding

Funds holding: 153 → 163 (+10)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

17% less capital invested

Capital invested by funds: $1.4B → $1.17B (-$231M)

Holders
163
Holders Change
+10
Holders Change %
+6.54%
% of All Funds
4.73%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
28
Increased
64
Reduced
47
Closed
17
Calls
$1.22M
Puts
$984K
Net Calls
+$235K
Net Calls Change
-$620K

Top Buyers

1
Franklin Resources
Franklin Resources
California
+$22M
2
Goldman Sachs
Goldman Sachs
New York
+$16.7M
3
BIT
BlackRock Institutional Trust
California
+$11.9M
4
TSW
Thompson Siegel & Walmsley
Virginia
+$8.2M
5
Renaissance Technologies
Renaissance Technologies
New York
+$8.14M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$66.1M
2
FAM
Fred Alger Management
New York
-$23.4M
3
JP Morgan Chase
JP Morgan Chase
New York
-$15.5M
4
BA
BlackRock Advisors
Delaware
-$13.1M
5
AG
Artal Group
Luxembourg
-$12.8M
Name Holding Trade Value Shares
Change 		Change in
Stake
Arrowstreet Capital
51
Arrowstreet Capital
Massachusetts
$3M +$3.34M +857 New
PAMU
52
Pictet Asset Management (UK)
United Kingdom
$2.94M -$975K -250 -23%
Public Sector Pension Investment Board (PSP Investments)
53
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$2.94M +$78K +20 +2%
New York State Common Retirement Fund
54
New York State Common Retirement Fund
New York
$2.85M +$27.3K +7 +0.9%
FWIA
55
Fort Washington Investment Advisors
Ohio
$2.79M -$721K -185 -19%
Macquarie Group
56
Macquarie Group
Australia
$2.73M +$292K +75 +11%
AllianceBernstein
57
AllianceBernstein
Tennessee
$2.66M – – –
SONJCPFA
58
State of New Jersey Common Pension Fund A
New Jersey
$2.63M – – –
MSA
59
Mason Street Advisors
Wisconsin
$2.52M +$19.5K +5 +0.7%
SIM
60
Spark Investment Management
New York
$2.38M +$456K +117 +21%
California Public Employees Retirement System
61
California Public Employees Retirement System
California
$2.37M +$7.8K +2 +0.3%
BlackRock
62
BlackRock
New York
$2.23M +$1.75M +450 +241%
California State Teachers Retirement System (CalSTRS)
63
California State Teachers Retirement System (CalSTRS)
California
$2.14M +$15.6K +4 +0.7%
CCIA
64
Campbell & Co Investment Adviser
Maryland
$2.13M +$253K +65 +12%
PP
65
PDT Partners
New York
$1.89M +$343K +88 +20%
ARTA
66
A.R.T. Advisors
New York
$1.7M +$655K +168 +53%
U
67
UBS
Switzerland
$1.68M +$940K +241 +101%
DCM
68
Dupont Capital Management
Delaware
$1.65M -$285K -73 -13%
MWNA
69
Marshall Wace North America
New York
$1.6M -$2.29M -588 -56%
MOACM
70
Mutual of America Capital Management
New York
$1.56M +$550K +141 +47%
RhumbLine Advisers
71
RhumbLine Advisers
Massachusetts
$1.47M -$140K -36 -8%
NFA
72
Nationwide Fund Advisors
Ohio
$1.41M -$27.3K -7 -2%
HI
73
HBK Investments
Texas
$1.4M +$1.56M +400 New
State Board of Administration of Florida Retirement System
74
State Board of Administration of Florida Retirement System
Florida
$1.4M -$3.9K -1 -0.3%
JP Morgan Chase
75
JP Morgan Chase
New York
$1.39M -$15.5M -3,984 -91%
1 2
3
4 5

ACOR Hedge Fund Activity: Q4 2013 in Review

163 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in Acorda Therapeutics (ACOR) for Q4 2013, worth a combined $1.17B — down 17% from $1.4B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new ACOR positions and 17 closed out — a net gain of 11 holders — while 64 added to existing stakes and 47 trimmed.

The largest buyer was Franklin Resources, opening a new position worth an estimated $22M. The largest seller was Fidelity Investments, cutting an estimated $66.1M.

  • 163 institutional investors held Acorda Therapeutics (ACOR) as of Q4 2013, up from 153 in Q3 2013.
  • Funds reported $1.17B of Acorda Therapeutics stock for Q4 2013, down 17% quarter-over-quarter.
  • 28 funds opened new Acorda Therapeutics positions in Q4 2013 and 17 closed out, a net change of +11 holders.
  • The largest Acorda Therapeutics buyer in Q4 2013 was Franklin Resources, an estimated $22M added.
  • The largest Acorda Therapeutics seller in Q4 2013 was Fidelity Investments, an estimated $66.1M sold.

Based on aggregated 13F filings for Q4 2013.